Corynebacterium diphtheriae

DB09877ApprovedInvestigationalVaccines

Corynebacterium diphtheriae toxin is extracted from the pathogenic actinobacterium C. diphtheriae that causes diphtheria. The bacteria culture is grown in a medium and through purification, diphtheria toxin is detoxified with... The vaccine is intramuscularly administered to provide active immunization against diphtheria in infants and children.

First approval: Canada, 2010 · United States, 1967

Resolves to

Compound

UNII3U7E3O07S8

What you can answer from here — as of April 02, 2025

92Clinical trialsPhase, status and sponsor resolved per trial

5Structured indicationsCondition, population, route and combination as fields, not prose

15Marketed productsAcross 5 countries and 5 labellers

Which other approved drugs treat the same conditions as Corynebacterium diphtheriae, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account